Patents by Inventor Shannon Hinson

Shannon Hinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and materials for identifying and treating autoimmune GFAP astrocytopathy
    Patent number: 12105088
    Abstract: This document provides methods and materials involved in identifying and treating autoimmune GFAP (glial fibrillary acidic protein) astrocytopathy, a novel meningoencephalomyelitis, in humans as well as methods and materials for identifying and offering early treatment for patients having autoimmune GFAP astrocytopathy whose autoantibody profile predicts a high likelihood of having underlying cancer (e.g., adenocarcinoma or teratoma).
    Type: Grant
    Filed: July 21, 2022
    Date of Patent: October 1, 2024
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Vanda A. Lennon, Andrew McKeon, Boyan Fang, Shannon Hinson, Thomas J. Kryzer
  • MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
    Publication number: 20240060975
    Abstract: The invention provides prognostic methods for evaluating the severity of NMO and NMO-associated diseases as well as methods of treating NMO and NMO-associated diseases.
    Type: Application
    Filed: May 5, 2023
    Publication date: February 22, 2024
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Vanda A. Lennon, Sean J. Pittock, Shannon Hinson
  • METHODS AND MATERIALS FOR IDENTIFYING AND TREATING AUTOIMMUNE GFAP ASTROCYTOPATHY
    Publication number: 20220357322
    Abstract: This document provides methods and materials involved in identifying and treating autoimmune GFAP (glial fibrillary acidic protein) astrocytopathy, a novel meningoencephalomyelitis, in humans as well as methods and materials for identifying and offering early treatment for patients having autoimmune GFAP astrocytopathy whose autoantibody profile predicts a high likelihood of having underlying cancer (e.g., adenocarcinoma or teratoma).
    Type: Application
    Filed: July 21, 2022
    Publication date: November 10, 2022
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Vanda A. Lennon, Andrew McKeon, Boyan Fang, Shannon Hinson, Thomas J. Kryzer
  • Methods and materials for identifying and treating autoimmune GFAP astrocytopathy
    Patent number: 11402379
    Abstract: This document provides methods and materials involved in identifying and treating autoimmune GFAP (glial fibrillary acidic protein) astrocytopathy, a novel meningoencephalomyelitis, in humans as well as methods and materials for identifying and offering early treatment for patients having autoimmune GFAP astrocytopathy whose autoantibody profile predicts a high likelihood of having underlying cancer (e.g., adenocarcinoma or teratoma).
    Type: Grant
    Filed: September 6, 2017
    Date of Patent: August 2, 2022
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Vanda A. Lennon, Andrew McKeon, Boyan Fang, Shannon Hinson, Thomas J. Kryzer
  • MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
    Publication number: 20220196652
    Abstract: The invention provides prognostic methods for evaluating the severity of NMO and NMO-associated diseases as well as methods of treating NMO and NMO-associated diseases.
    Type: Application
    Filed: December 29, 2021
    Publication date: June 23, 2022
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Vanda A. Lennon, Sean J. Pittock, Shannon Hinson
  • MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
    Publication number: 20200393462
    Abstract: The invention provides prognostic methods for evaluating the severity of NMO and NMO-associated diseases as well as methods of treating NMO and NMO-associated diseases.
    Type: Application
    Filed: July 1, 2020
    Publication date: December 17, 2020
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Vanda A. Lennon, Sean J. Pittock, Shannon Hinson
  • METHODS AND MATERIALS FOR IDENTIFYING AND TREATING AUTOIMMUNE GFAP ASTROCYTOPATHY
    Publication number: 20190376965
    Abstract: This document provides methods and materials involved in identifying and treating autoimmune GFAP (glial fibrillary acidic protein) astrocytopathy, a novel meningoencephalomyelitis, in humans as well as methods and materials for identifying and offering early treatment for patients having autoimmune GFAP astrocytopathy whose autoantibody profile predicts a high likelihood of having underlying cancer (e.g., adenocarcinoma or teratoma).
    Type: Application
    Filed: September 6, 2017
    Publication date: December 12, 2019
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Vanda A. Lennon, Andrew McKeon, Boyan Fang, Shannon Hinson, Thomas J. Kryzer
  • MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
    Publication number: 20190242892
    Abstract: The invention provides prognostic methods for evaluating the severity of NMO and NMO-associated diseases as well as methods of treating NMO and NMO-associated diseases.
    Type: Application
    Filed: December 12, 2018
    Publication date: August 8, 2019
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Vanda A. Lennon, Sean J. Pittock, Shannon Hinson
  • MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
    Publication number: 20180246093
    Abstract: The invention provides prognostic methods for evaluating the severity of NMO and NMO-associated diseases as well as methods of treating NMO and NMO-associated diseases.
    Type: Application
    Filed: January 4, 2018
    Publication date: August 30, 2018
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Vanda A. Lennon, Sean J. Pittock, Shannon Hinson
  • Methods for treating neuromyelitis optica (NMO) by administration of eculizumab to an individual that is aquaporin-4 (AQP4)-IgG autoantibody positive
    Patent number: 9891219
    Abstract: The invention provides prognostic methods for evaluating the severity of NMO and NMO-associated diseases as well as methods of treating NMO and NMO-associated diseases.
    Type: Grant
    Filed: October 6, 2009
    Date of Patent: February 13, 2018
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Vanda A. Lennon, Shannon Hinson, Sean J. Pittock
  • MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
    Publication number: 20150104813
    Abstract: The invention provides prognostic methods for evaluating the severity of NMO and NMO-associated diseases as well as methods of treating NMO and NMO-associated diseases.
    Type: Application
    Filed: August 27, 2014
    Publication date: April 16, 2015
    Inventors: Vanda A. Lennon, Shannon Hinson, Sean J. Pittock
  • MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
    Publication number: 20140030262
    Abstract: The invention provides prognostic methods for evaluating the severity of NMO and NMO-associated diseases as well as methods of treating NMO and NMO-associated diseases.
    Type: Application
    Filed: October 2, 2013
    Publication date: January 30, 2014
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Vanda A. Lennon, Shannon Hinson, Sean J. Pittock
  • MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
    Publication number: 20100092478
    Abstract: The invention provides prognostic methods for evaluating the severity of NMO and NMO-associated diseases as well as methods of treating NMO and NMO-associated diseases.
    Type: Application
    Filed: October 6, 2009
    Publication date: April 15, 2010
    Inventors: Vanda A. Lennon, Shannon Hinson, Sean J. Pittock